QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.107557v1 319/3/1355    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katnik, C. Articles by Cuevas, J. Search for Related Content PubMed PubMed Citation Articles by Katnik, C. Articles by Cuevas, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL CARBETAPENTANE CYCLOPENTANE N,N'-BIS(2-METHYLPHENYL)GUANIDINE PENTAZOCINE PHENCYCLIDINE SODIUM AZIDE TETRODOTOXIN

NEUROPHARMACOLOGY

Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia

Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa, Florida

Sigma receptors are putative targets for neuroprotection following ischemia; however, little is known on their mechanism of action. One of the key components in the demise of neurons following ischemic injury is the disruption of intracellular calcium homeostasis. Fluorometric calcium imaging was used to examine the effects of sigma receptor activation on changes in intracellular calcium concentrations ([Ca²⁺]_i) evoked by in vitro ischemia in cultured cortical neurons from embryonic rats. The sigma receptor agonist, 1,3-di-o-tolyl-guanidine (DTG), was shown to depress [Ca²⁺]_i elevations observed in response to ischemia induced by sodium azide and glucose deprivation. Two sigma receptor antagonists, metaphit [1-(1-(3-isothiocyanatophenyl)-cyclohexyl)-piperidine] and BD-1047 (N-[2–3,4-dichlorophenyl)-ethyl]-N-methyl-2-(dimethylamino)ethylamine), were shown to blunt the ability of DTG to inhibit ischemia-evoked increases in [Ca²⁺]_i, revealing that the effects are mediated by activation of sigma receptors and not via the actions of DTG on nonspecific targets such as N-methyl-D-aspartate receptors. DTG inhibition of ischemia-induced increases in [Ca²⁺]_i was mimicked by the -1 receptor-selective agonists, carbetapentane, (+)-pentazocine and PRE-084 [2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochloride], but not by the sigma-2-selective agonist, ibogaine, showing that activation of sigma-1 receptors is responsible for the effects. In contrast, DTG, carbetapentane, and ibogaine blocked spontaneous, synchronous calcium transients observed in our preparation at concentrations consistent with sigma receptor-mediated effects, indicating that both sigma-1 and sigma-2 receptors regulate events that affect [Ca²⁺]_i in cortical neurons. Our studies show that activation of sigma receptors can ameliorate [Ca²⁺]_i dysregulation associated with ischemia in cortical neurons and, thus, identify one of the mechanisms by which these receptors may exert their neuroprotective properties.

Address correspondence to: Dr. Javier Cuevas, Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 9, Tampa, FL 33612-4799. E-mail: jcuevas{at}hsc.usf.edu

This article has been cited by other articles:

				S. B. Smith, J. Duplantier, Y. Dun, B. Mysona, P. Roon, P. M. Martin, and V. Ganapathy In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4154 - 4161. [Abstract] [Full Text] [PDF]

				K. T. Tchedre and T. Yorio {sigma}-1 Receptors Protect RGC-5 Cells from Apoptosis by Regulating Intracellular Calcium, Bax Levels, and Caspase-3 Activation Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2577 - 2588. [Abstract] [Full Text] [PDF]

				Y. Dun, M. Thangaraju, P. Prasad, V. Ganapathy, and S. B. Smith Prevention of Excitotoxicity in Primary Retinal Ganglion Cells by (+)-Pentazocine, a Sigma Receptor-1 Specific Ligand Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4785 - 4794. [Abstract] [Full Text] [PDF]